Pharmaceutical Technology2 天
Calquence by AstraZeneca for Graft Versus Host Disease (GVHD): Likelihood of Approval
Calquence is under clinical development by AstraZeneca and currently in Phase II for Graft Versus Host Disease (GVHD).
Pharmaceutical Technology3 天
Calquence by AstraZeneca for Coronavirus Disease 2019 (COVID-19): Likelihood of Approval
Calquence is under clinical development by AstraZeneca and currently in Phase I for Coronavirus Disease 2019 (COVID-19).